Table 1.
Socio-demographic and clinical characteristics among children and adolescents living with HIV in Tanzania (CALHIV) (N = 63,453)
| Characteristics | Frequency | Percentage |
|---|---|---|
| Sex | ||
| Male | 27,345 | 43.1 |
| Female | 36,108 | 56.9 |
| Baseline age (years) | ||
| 1–4 | 21,852 | 34.4 |
| 5–9 | 20,009 | 31.5 |
| 10–14 | 11,707 | 18.5 |
| 15–19 | 9,885 | 15.6 |
| Mean (± SD) | 7.74 (5.37) | |
| Base WHO clinical staging | ||
| Stage I | 26,026 | 41.0 |
| Stage II | 18,026 | 29.5 |
| Stage III | 16,112 | 25.4 |
| Stage IV | 2,565 | 4.0 |
| Baseline CD4 cells/mm3 (n = 35,478) | ||
| < 200 | 3,101 | 8.7 |
| 200–349 | 1,905 | 5.4 |
| >=350 | 30,472 | 85.9 |
| Median (IQR) | 427 (162–742) | |
| Baseline BMI (Kg/M2) (n = 23,687) | ||
| Underweight | 18,478 | 78.0 |
| Normal | 3,312 | 13.9 |
| Overweight | 510 | 2.2 |
| Obesity | 1,387 | 5.9 |
| Median (IQR) | 15.6 (13.9–17.9) | |
| Prior DTG status (n = 54,531) | ||
| Experienced suppressed | 34,557 | 63.4 |
| Experienced unsuppressed | 13,041 | 23.9 |
| Naive | 6,933 | 12.7 |
| Duration on ART | ||
| 6–12 months | 3,833 | 6.0 |
| 13–24 months | 6,108 | 9.6 |
| > 24 months | 53,512 | 84.3 |
| DTG regimen (n = 63,303) | ||
| TDF + 3TC + DTG (TLD) | 38,645 | 61.0 |
| ABC + 3TC + DTG | 22,578 | 35.7 |
| AZT + 3TC + DTG | 2,080 | 3.3 |
| Ever received MMS | ||
| No | 7,476 | 11.8 |
| Yes | 55,977 | 88.2 |
| Child exposed to PMTCT | ||
| No | 58,217 | 91.7 |
| Yes | 5,236 | 8.3 |
| History of TB treatment | ||
| No | 57,592 | 90.8 |
| Yes | 5,861 | 9.2 |
| Current malnutrition status (n = 56,083) | ||
| No malnutrition | 55,601 | 99.1 |
| Mild & moderate | 450 | 0.8 |
| Severe | 32 | 0.1 |
| Regimen | ||
| First line | 56,870 | 89.6 |
| Second line | 6,583 | 10.4 |
| Retention in care | ||
| In care | 63,047 | 99.4 |
| Lost to follow up | 24 | 0.1 |
| Transferred | 65 | 0.1 |
| Died | 317 | 0.4 |
| Facility type (n = 63,136) | ||
| Dispensary | 15,494 | 24.5 |
| Health centre | 20,665 | 32.7 |
| Hospital | 26,977 | 42.7 |
| Facility ownership (n = 63,136) | ||
| Private/FBO | 15,066 | 23.9 |
| Public | 48,070 | 76.1 |
| Zone (n = 63,136) | ||
| Central zone | 6,510 | 10.3 |
| Coastal zone | 13,400 | 21.2 |
| Lake zone | 17,152 | 27.2 |
| Northern zone | 7,536 | 11.9 |
| Southern highland | 16,907 | 26.8 |
| Western zone | 1,631 | 2.6 |
Frequency (n) do not tally to the total due to missing values
MMS multi-month subscription; PMTCT prevention of mother to child transmission; TB tuberculosis; BMI body mass index; CD4 cluster of differentiation 4; ART antiretroviral therapy; FBO Faith based organizations; DTG dolutegravir; TDF tenofovir; 3TC lamivudine; ABC abacavir; AZT azidothymidine (Zidovudine); ART antiretroviral therapy